中银创新医疗混合C(010500)资产负债表
|
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
资产 |
银行存款 |
- |
- |
- |
66,346,519.08 |
结算备付金 |
4,345,545.62 |
6,740,278.15 |
27,746,907.12 |
5,871,446.90 |
存出保证金 |
368,518.89 |
358,689.28 |
500,968.10 |
806,974.90 |
交易性金融资产 |
2,984,689,393.54 |
2,259,083,966.45 |
2,580,333,056.12 |
2,260,742,890.28 |
其中:股票投资 |
2,822,068,235.02 |
2,128,655,943.61 |
2,435,245,776.01 |
2,111,002,157.27 |
债券投资 |
162,621,158.52 |
130,428,022.84 |
145,087,280.11 |
149,740,733.01 |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
- |
6,684,300.78 |
42,636,420.16 |
329,005.84 |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
669,756.33 |
- |
475,410.85 |
应收申购款 |
2,771,516.56 |
5,337,717.46 |
4,960,656.45 |
577,767.73 |
其他资产 |
- |
- |
- |
- |
资产总计 |
3,042,453,159.67 |
2,290,364,766.20 |
2,685,052,191.11 |
2,335,150,015.58 |
负 债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
10,854,369.95 |
3,574,739.72 |
33,222,757.88 |
1,596,792.62 |
应付赎回款 |
19,724,334.47 |
876,343.40 |
1,553,235.17 |
38,230,886.63 |
应付管理人报酬 |
3,120,566.87 |
2,347,785.69 |
2,864,731.08 |
3,085,099.33 |
应付托管费 |
520,094.50 |
391,297.61 |
477,455.19 |
514,183.24 |
应付销售服务费 |
284,686.95 |
255,547.81 |
375,625.76 |
298,689.10 |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
- |
- |
- |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
854,828.80 |
791,386.76 |
1,644,092.39 |
4,203,545.40 |
负债合计 |
35,358,881.54 |
8,237,100.99 |
40,137,897.47 |
47,929,196.32 |
所有者权益 |
实收基金 |
2,511,352,384.30 |
2,022,614,601.10 |
1,952,930,603.77 |
1,813,193,863.14 |
未分配利润 |
495,741,893.83 |
259,513,064.11 |
691,983,689.87 |
474,026,956.12 |
所有者权益合计 |
3,007,094,278.13 |
2,282,127,665.21 |
2,644,914,293.64 |
2,287,220,819.26 |
负债及所有者权益总计 |
3,042,453,159.67 |
2,290,364,766.20 |
2,685,052,191.11 |
2,335,150,015.58 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年